angiotensin ii has been researched along with sbi-0206965 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, YY; Chen, HY; He, JH; Jiang, W; Lan, J; Li, H; Li, RL; Li, X; Tang, CS; Wang, W; Wang, XX; Wu, SS; Wu, Y; Xin, JJ; Xue, KY; Zhang, HY; Zhuo, CL | 1 |
1 other study(ies) available for angiotensin ii and sbi-0206965
| Article | Year |
|---|---|
Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cardiomegaly; Fibronectins; Heart Failure; Humans; Mice; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Pressure; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |